BSECompany Update1d ago · 24 Sept 2026, 07:41 pm
Please refer to our intimation under Regulation 30 for withdrawal of proposed preferential issue of 45,95,795 convertible equity warrants.
Themis Medicare Ltd · 530199
✦ AI SummaryFundraise
Themis Medicare Ltd has withdrawn its proposed preferential issue of 45,95,795 convertible equity warrants, citing a need to consider fresh issues in the future to meet the company's working capital requirements.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Themis Medicare Ltd - 530199 - Announcement Under Regulation 30 Of LODR - Withdrawal Of Proposed Preferential Issue.
Attachments (1)
📄pdf
Download →
3545d94e-e39e-4957-97b3-ccc407db61df.pdf
View document text
TML/BSE/NSE/2026-27/27 24th September, 2026
Corporate Relationship Department Listing Department
BSE Limited National Stock Exchange of India Limited
Floor 25, Phiroze Jeejeebhoy Towers Exchange Plaza,
Dalal Street, Mumbai- 400001 Bandra Kurla Complex,
Scrip Code – 530199 Bandra (East), Mumbai- 400051
Symbol: THEMISMED
Sub.: Withdrawal of proposed Preferential Issue of 45,95,795 convertible equity
warrants.
Dear Sir / Madam,
We refer to our intimation dated February 25, 2026 informing approval by the
Preferential Issue Committee of the Board for proposal to issue of warrants
convertible into equity shares to the promoters group entity by way of preferential
issue of 45,95,795 warrants at a price of Rs. 102.87 per warrant (the Issue) and further
intimation dated March 10, 2026 in this respect. We further update you that it
decided today to withdraw the proposed Issue.
The reasons for withdrawing the Issue include with a view to consider fresh issue in
future with such objects as may be necessary or to meet requirement of the
Company in future as and when necessary. The objective of the Issue was mainly to
strengthen working capital requirement of the Company, which now have been
arranged and met by way of other means.
The Company has made application for an in-principal approval for the above
proposed Issue to BSE Limited (BSE) and National Stock Exchange of India Limited
(NSE). The Company will withdraw the said applications. Accordingly, all disclosures /
intimations / submissions including made to the Stock Exchanges in connection with
this preferential issue be treated as withdrawn.
We hereby clarify and assure you that the withdrawal of the above-mentioned
proposed Issue shall not have any adverse impact on the financial position and
operations of the Company.
Thanking you
Yours faithfully
For Themis Medicare Limited
Dr. Sachin Patel
Managing Director
DIN: 00033273
Themis Medicare Limited
Corporate Office: 11/12 Udyog Nagar, S V Road, Goregaon (W), Mumbai – 400 104, India
*Tel.: 91-22-67607080*Fax: 91-22-67607070/ 28746621
Regd. Office: Plot No. 69-A, G.I.D.C., Industrial Estate, Vapi-Gujarat
CIN No.: L24110GJ1969PLC001590 *Tel/ Fax No.: Regd. Off.: 0260-2431447/ 2430219
*E-mail: themis@themismedicare.com*Website: www.themismedicare.com